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Abstract
Background: In the last few years, excessive internet use and computer gaming have increased dramatically.
Salience, mood modification, tolerance, withdrawal symptoms, conflict, and relapse have been defined as diagnostic
criteria for internet addiction (IA) and computer addiction (CA) in the scientific community. Despite a growing
number of individuals seeking help, there are no specific treatments of established efficacy.
Methods/design: This clinical trial aims to determine the effect of the disorder-specific manualized short-term
treatment of IA/CA (STICA). The cognitive behavioural treatment combines individual and group interventions with
a total duration of 4 months. Patients will be randomly assigned to STICA treatment or to a wait list control group.
Reliable and valid measures of IA/CA and co-morbid mental symptoms (for example social anxiety, depression) will
be assessed prior to the beginning, in the middle, at the end, and 6 months after completion of treatment.
Discussion: A treatment of IA/CA will establish efficacy and is desperately needed. As this is the first trial to
determine efficacy of a disorder specific treatment, a wait list control group will be implemented. Pros and cons of
the design were discussed.
Trial Registration: ClinicalTrials (NCT01434589)
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Background
The internet has become accessible for the great majority
of the population (for example flat rates, WLAN, or port-
able computers). In a representative German sample
(n= 2475) in 2009 the rate of leisure-time internet users
for women was about 51% and for men about 60%. The
most frequently used internet applications were email
(93%), information and research (92%), shopping (76%),
and chatting (62%) [1]. In 2004 about 68% of American
adults used the internet regularly and 4% to 14% showed
one or more markers of problematic use with a prevalence
of internet addiction (IA) at about 1% [2], which is con-
cordant with an actual German study [3]. The onset of
manifest addicted behavior is reported in the late 20s or
early 30s age groups [2]. In epidemiological studies, preva-
lence rates of addicted internet use and computer game
behavior range between 1.5% to 3.0% in German [3,4] and
Austrian [5] adolescents, respectively.
According to Block [6], three subtypes of IA/computer
game addiction (CA) (excessive gaming, sexual preoccupa-
tions, and email/text messaging) have four components in
common: (a) excessive use (along with a loss of sense of
time or the ignorance of basic drives); (b) withdrawal (for
example tension, anger, agitation, and/or depression when
access to a computer is blocked; (c) tolerance (increasing
use or sophistication of computer equipment); and (d)
negative repercussions (for example poor achievement/
performance, fatigue, social isolation, or conflicts).
Salience, mood modification, tolerance, withdrawal
symptoms, conflict, and relapse are additional diagnostic
criteria for IA and CA [7]. The addicted individual is in-
creasingly attracted towards the excessive behavior and
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life is emotionally and cognitively preoccupied with the
application (for example computer game), requiring
more and more time in order to regulate his mood
states. Empirical studies [4,8,9] have demonstrated that
the symptom complex of IA/CA [10,11] matches the cri-
teria of substance disorders. Results of neurobiological
studies have identified neurophysiological mechanisms in
IA/CA equivalent to substance abuse (alcohol [12] and
cannabis addiction [13]).
Patients with CA and IA have increasingly sought help
in addiction counseling [14], because of serious negative
psychosocial consequences (social, work/education, health)
which have been documented along with high mental co-
morbidities [15-19]. IA is strongly associated with dimen-
sionally measured depression [18,20], indicators of social
isolation or behavioral deficits (for example ADHD
[18,21,22]), or impulsivity [23]. In the Grüsser-Sinopoli
outpatient clinic for behavioral addiction, from 2008 to
2010, a total of 326 patients have been assessed for IA/CA
by clinical examination and tests. Of those, 192 patients
were classified as IA/CA. They were predominantly (97%)
male and aged from 18 to 30 years. They showed strong
evidence of social phobia and depression as well as per-
formance decrements in school and work.
Despite its increasing importance as a major health
problem among adolescents and young adults at present,
there is still a lack of evidence-based interventions for
IA/CA. Preliminary evidence has only been generated in
open trials for non-European and Asian populations
[24,25].
Therefore, a specific short-term treatment program for
IA/CA, based on cognitive behavior therapy (STICA) was
developed. A preliminary evaluation of the manualized
STICA treatment was performed in an open trial of the
Grüsser-Sinopoli outpatient clinic for behavioral addiction
with a total of 33 patients. Twenty-four out of this sample
completed STICA regularly, nine patients terminated treat-
ment prematurely and were considered as drop-outs (27%).
Based on the full sample of 33 patients (intent to treat ana-
lysis) criteria for treatment response (primary efficacy end-
point) were reached by 67% which corresponds to a large
effect size of 1.27 [Wölfling K, Müller KW, Beutel ME:
Treatment outcome of a manualized cognitive behavior
therapy in Internet and Computer game addiction,
unpublished].
This study will assess the efficacy of the manualized
STICA. Furthermore, the durability of treatment re-
sponse in these patients and the impact on associated
psychiatric symptoms (for example social anxiety and
depression) will be determined. Currently STICA is the
only manualized outpatient treatment program for IA/
CA in Germany [26] and further international concepts




This multicenter study is coordinated by the outpatient
clinic for behavioral addictions of the Clinic for Psycho-
somatic Medicine and Psychotherapy of the University
Medical Center Mainz. Three centers will further partici-
pate, the Anton-Proksch-Institute, Austria, the Section
Addiction Medicine and Addiction Research of the Uni-
versity Hospital Tübingen, and the Addiction Medicine
of the Central Institute of Mental Health in Mannheim.
Investigators in all centers are psychotherapists (physi-
cians or psychologists) and experts in the treatment of
addiction behavior.
Participants
Patients will be included, if the following eight inclusion
criteria are fulfilled: (1) IA/CA according to the AICA
(Assessment of Internet and Computer game Addiction)
expert rating for at least 6 months and (2) a score ≥ 7 in
the AICA self-report IA/CA. (3) Patients with co-morbid
disorders will be included, provided that IA/CA is the
primary diagnosis. The study will only include (4) men
in (5) the age between 17 and 45 years. (6) If the patients
are currently on psychotropic medications, no changes
in medications and dosages in the past 2 months and
during STICA treatment are allowed. (7) If currently off
all psychotropic medications, patient must have been off
at least 4 weeks. (8) During STICA no other ongoing
psychotherapy is allowed and previous psychotherapy
must have been completed for at least 4 weeks.
Patients with a score <40 in the Global Assessment of
Functioning (GAF [28]) or severe major depression
(Beck Depression Inventory; BDI-II [29] ≥ 29) are
excluded. Additional exclusion criteria are current alco-
hol or drug addictions, borderline, antisocial, schizoid,
and schizotypal personality disorders, a lifetime diagnosis
of schizophrenia, schizoaffective, bipolar, or organic
mental disorder and a current unstable medical illness.
Over a time period of 36 months we plan to include 192
patients in the study. The patients will be randomly
assigned to the intervention or to the wait list control
group (WLC). Prior to randomization, a total of 18 patients
have to be allocated to the trial. The intervention group will
start treatment immediately after randomization, whereas
the WLC group has to wait over a period of 4 months, until
they will receive the same therapy.
Intervention
The manualized STICA [26] is based on a cognitive be-
havior approach and combines group with individual
therapy. STICA comprises 23 psychotherapy sessions
with a total duration of 4 months. Fifteen out of twenty-
three sessions will be weekly group sessions (100 min
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each) and eight will be fortnightly individual sessions
(50 min).
Table 1 shows treatment phases and strategies during
the early, middle, and termination phases. Based on
understanding the mechanisms and the consequences of
IA/CA (early phase), patients are trained to identify the
triggers of their own dysfunctional internet use. By using
diaries, social skill training, and exposition training,
patients learn to reduce and to control their computer
and internet use. In the termination phase of treatment,
tools will be transferred to daily life and strategies for
relapse prevention will be discussed.
Assessment
Figure 1 shows a flow chart of the five time points of
assessment. At T0a patients are informed about the
study and assessed for eligibility. Patients fill out the
AICA-S [30,31, Müller KW, Glaesmer H, Brähler E,
Wölfling K, Beutel M; Internet addiction in the general
population. Results from a german population-based
survey. unpublished] and the BDI-II [29]. AICA-S values
range between 0 and 27, and scores ≥ 7 have been
defined as problematic internet use. Therapists assess
onset, course, and criteria of IA/CA, treatment history,
motivation for therapy, and the GAF [28]. The AICA
Checklist will be rated by an independent and blinded
rater.
The assessment T0b is performed immediately before
randomization and commencement of treatment. The
criteria for IA/CA will be rechecked by self-report mea-
surements, if the delay due to the group recruitment
exceeds 2 weeks. Therapists fill out the GAF [28] and
collect information about medications, other therapies,
and treatment history. An independent and blinded rater
will assess mental disorders with the SCID-I/II [32] and
conduct the AICA-Checklist. A drug screening is further
used to assess objective information on drug consump-
tion. Self-report assessment includes IA/CA (AICA-S
[30,31]), depression (BDI-II [29]), obsessive-compulsive
behavior (SCL-90-R [33]), generalized anxiety and panic
(Patient Health Questionnaire [34]), somatization [34],
general distress [34], depersonalization (CDS-2 [35]), and
social fear (LSAS [36]). Patients also fill out dimensions
of personality (NEO-FFI [37]), attention deficit disorder
(WURS-k [38]), self-efficacy (SWE [39,40]), positive and
negative affectivity (PANAS [41]), and adverse childhood
experiences (ACE [42]). Finally, they answer questions
concerning perceived stress (PSS [43]) and about their
life satisfaction (FLZ [44]). Attention of the patients will
be checked with the d2 [45].
After 2 months of therapy (T1) patient-rated outcome
measures are reapplied (AICA, GAF, BDI-II) and drug
screening repeated. The outcome measures are supple-
mented by assessments of group climate (GCQ [46]) and
therapeutic alliance (HAQ [47]).
Immediately after completion of the intervention (T2)
patients fill out a set of questionnaires identical with
the set at T0b, except for the trait measures (NEO-FFI,
WURS-k, ACE). Group climate and therapeutic alliance
are assessed additionally. Drug screening is applied and
is obligatory. For patients of the WLC group this is the
final assessment. Shortly after the survey their intervention
will start.
Patients of the intervention group are asked to evaluate
the stability of treatment effects 6 months after termination
of treatment (T3). Thereby the used set of questions corre-
sponds to T2.
Data collection
In this study there are two sources of electronic study
data. An eCRF has been developed for the investigators
to document their study data in a database stored,
maintained, and administered by the IZKS Mainz. It is
Table 1 STICA Treatment phases and strategies
Treatment phase Key interventions
Early phase Patient education on mechanisms and effects
of IA/CA (for example learning theories,
development and consequences of IA/CA,
vicious cycles of addiction, and so on)
Promotion of social communication and
bonding in the group and individual setting
Middle phase Identification of the triggers of dysfunctional
internet use (for example emotional states,
maladaptive cognitions, daily hassles, and so
on) by keeping diaries
Functional analysis of the addictive behavior
Enabling functional internet use by appropriate
problem-solving strategies
Assisting the establishment of a social network
in real life
Building alternative activities
Self-monitoring to reduce procrastination
tendencies
Promotion of social communication
Exposition training (confronting and deleting
access to critical applications, for example the
self-created avatar)
Skill training (for example coping with stress
and problems, social skills, building alternative
activities, and so on)




Review of transfer of treatment tools to daily
life
Functional computer/internet use
Elaboration of tools preventing a relapse
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password protected with individual accounts for all
investigators.
Patients will answer the self-report questionnaires by
entry forms customized for iPADs. Each patient receives
only access to his own current questionnaire.
After data collection, eCRF and iPAD data will be
transformed into one SAS database for evaluation.
Objectives and hypotheses
The purposes or this study are to determine the effi-
cacy of STICA, to assess the durability of treatment
response in these patients, and the impact on asso-
ciated mental symptoms (for example social anxiety
and depression).
Outcomes
The primary efficacy endpoint is defined as improvement
of IA/CA rated by the patient himself (primary outcome
measure: AICA-S [30,31]). At the end of therapy an
AICA-S score <7 indicates remission.
Secondary endpoints include the remission of IA/CA
in the expert rating (AICA-C ≤ 13). The preoccupation
with the internet or computer games will be analyzed
(hours spent per week). IA and CA are associated with
negative consequences in health, social communica-
tion, psychosocial wellbeing (GAF [28], BDI-II [30],
LSAS [36]), level of performance in school or work,
and self-efficacy (SWE [39]). For each instrument
assessments at baseline will be compared to assess-
ments obtained 4 and 6 months after therapy.
Figure 1 Flow chart of the study. Patients of the wait list control group (WLC) will be offered STICA treatment after the intervention group has
finished. The follow-up analysis will be performed separately for WLC.
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Sample size calculation
The sample size calculation is based on the primary end-
point (T2: end of therapy) and a chi-square test without
continuity correction on a two-sided level of significance
of 0.05. The calculation is based on results from 33
patients, who participated in an open trial. Twenty-four
patients improved according to the AICA-S< 7. A differ-
ence to the control group of 20% is considered as clinic-
ally relevant. With a power of 90%, 184 patients in total
are needed to detect that difference. Considering the
average therapy group size of eight, 16 subjects have to
be randomized at the same time. Therefore, we will need
to include 192 patients in this trial (n= 96 patients for
each group). The primary analysis will be performed on
the population of all randomized subjects (intention to
treat (ITT) population). Subjects who discontinue the
therapy will be regarded as non-improvers to treatment.
Our previous experience with internet addicts revealed
drop-out rates of about 27% (nine drop-outs from 33
patients).
Randomization
Patients will be randomly assigned either to the STICA
intervention group or to the WLC group. The
randomization list will be generated stratified by the
Interdisciplinary Centre for Clinical Trials (IZKS). Con-
sidering the average therapy group size of eight patients,
16 patients have to be randomized at the same time. The
randomization ratio will be 1:1 within each center. After
confirmation that a patient fulfils all inclusion criteria for
randomization, the electronic case report form (eCRF)
will immediately provide the investigator with the
randomization results. Patients are subsequently
informed about the randomization result and the inter-
vention starts shortly after randomization. The IZKS will




The primary efficacy endpoint is defined as the change
of the AICA-S level. This will be analyzed using a logistic
regression model with predictors of group (STICA treat-
ment vs. WLC), pre-treatment score of AICA-S, educa-
tion, trial center, and age.
The primary hypothesis to be tested is:
H0: πSTICA = πWLC vs. H1: πSTICA 6¼πWLC
where πSTICA and πWLC are the probabilities to respond
to treatment in the STICA treatment group and the WLC
group, respectively. The primary analysis will be performed
on the ITT population on a two-sided level of significance
α=0.05. The two-sided level of significance will be the
same for all analyses. A completer analysis will be per-
formed for sensitivity. Additionally, the analysis will be
repeated with a predictor for the therapy group. Drop-outs
during the treatment phase will be regarded as treatment
failures.
Secondary analysis
The remission of IA/CA according to the AICA Check-
list will be examined using logistic regression analyses
with the same predictors as the primary analysis. The re-
duction of negative consequences, GAF, depression
(BDI-II), and social anxiety (LSAS) will be examined
using ANCOVA with covariates.
Analyses will be conducted on a two-sided level of
significance of α = 0.05. Descriptive statistics are used
to show changes over time. Serious adverse events
and drop-outs will be analyzed by using descriptive
statistics.
Safety aspects
Safety parameters will comprise newly occurring psychi-
atric diagnoses (SCID-I [32]) and all serious adverse
events that are reported during and up to 6 months after
treatment. Therefore in the context of psychotherapy
suicidal ideations or the global functioning level will be
regarded.
Medical complications
According to GCP, an adverse event (AE) is defined as
follows: any untoward medical occurrence in a patient
participating in a clinical trial. An AE can therefore be
any unfavorable and unintended sign (including an ab-
normal laboratory finding), symptom, or disease, whether
or not related to the trial intervention. Due to the fact
that this trial analyses a psychological treatment, only
AEs concerning psychological conditions, defined as any
disorder classified by the International Classification of
Diseases [48] F00-F99 (‘Mental and Behavioral Disor-
ders’) will be documented.
For this study the following conditions were defined as
AE: (1) new symptoms/medical conditions, (2) new diag-
nosis, (3) intercurrent diseases and accidents, (4) wor-
sening of medical conditions/diseases existing before
clinical trial start, (5) recurrence of disease, or (6) in-
crease of frequency or intensity of episodical diseases.
A serious adverse event (SAE) is an AE that: (1) results
in death, (2) is life-threatening, (3) requires patient
hospitalization or prolongation of existing hospitalization,
(4) results in persistent or significant disability/incapacity,
or (5) is a congenital anomaly/birth defect.
All medical complications during the study are docu-
mented in the eCRF.
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Ethical issues
Clinical protocol and written informed consent were
approved by the Ethics Committee (EC) of the Federal
State of Rhineland Palatinate (Germany), which is re-
sponsible for the coordinating centre Mainz (Ref. No.
837.316.11 (7858)). Ethics Committees of all cooperating
centers will provide the necessary additional documents.
All procedures described in the clinical trial protocol
follow the ICH-GCP guidelines and the ethical principles
described in the current revision of the Declaration of
Helsinki. The trial will be carried out in keeping with
local legal and regulatory requirements.
Before being admitted to the clinical trial, patients re-
ceive detailed explanations of the nature, scope, and pos-
sible consequences of the clinical trial in a form
understandable to them. The patients must give consent
in writing. Each patient will receive a copy of the signed
informed consent document.
In this clinical trial all patients, including the WLC
group will receive the full treatment. For the WLC
patients the therapy begins after a waiting period of
4 months.
An independent Data Monitoring and Safety Board
(DMSB) has been established for this study. The DMSB
will supervise the conduct of this trial and will issue
recommendations for early termination, modifications or
continuation of the trial, if necessary. The DMSB and
the EC must be informed immediately of study-related
SAE.
Discussion
The number of patients suffering from IA/CA who need
professional help increases constantly. Up to now there
is no specific manualized intervention program and there
are no well-defined treatments of established efficacy. To
our knowledge, STICA is the very first clinical trial for
establishing efficacy of a specific treatment for IA/CA.
The efficacy of the treatment will be checked in a ran-
domized controlled multicenter trial. The use of a WLC
group appears to be justified because of the novel treat-
ment approach and the lack of comparable approaches.
Patients in the WLC are assured to receive full treat-
ment after a waiting period of 4 months following
randomization. Thus, however, follow-up of waitlist
controls is not possible.
STICA will also regard co-morbid mental disorders and
serious long-term consequences (for example social with-
drawal or failure in school/education) caused by excessive
internet or computer game use. The aim of STICA is the
reintegration of the patients into a normal life, including
controlled use of computer and internet, social contacts,
and work performance.
The results of this study will be of high relevance because
of the methodological demand and the high relevance of
the topic. This study will determine the effectiveness
and durability of a cognitive behavioral short-term treat-
ment for IA/CA. For patient care it will be important to
implement an effective treatment for IA/CA in clinical
routine.
Trial status
The first patient was enrolled to the STICA study on
February 1, 2012. Follow-up measures for the last
included patients were expected to be terminated in June
2014.
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